CompletedNot Applicable

Feasibility of a Self-performed Urinary Test for the Follow-up on Medical Abortion

France322 participantsStarted 2013-05

Plain-language summary

This study was a national, longitudinal, prospective, observational survey, carried out in metropolitan France, with a sampling of 21 birth control centres. The aim of this study was to assess, in real life conditions, the benefit of a urinary semi-quantitative test (hCG Duo 5-1000) in the follow-up of medical abortion by analysing the concordance between qualitative results from the urinary test and quantitative values from the beta-hCG blood measurement.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult women (18 years old or more), pregnant the day of the medical examination and asking for medical abortion. * Patients agreeing to participate in the study after have been informed orally by the physician and given the information sheet. * Informed patients accepting the computer processing of their medical data and their right of access and correction. Exclusion Criteria: * Patients with more than 49 Days of Amenorrhea (DA) for private practice and 63 DA for hospital practice. * Patients with contraindications to medical abortion. * Patients with severe and progressive disease. * Patients unable to complete a questionnaire. * Patients refusing to participate in the study.

What they're measuring

concordance between qualitative results from the urinary test and quantitative values from the beta-hCG blood measurement.

Timeframe: At the follow-up at 2-3 weeks after inclusion

Trial details

NCT IDNCT02304835

SponsorNordic Pharma SAS

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2013-11

View on ClinicalTrials.gov More Abortion; Attempted, Medical trials